This company has been marked as potentially delisted and may not be actively trading. NASDAQ:NARI Inari Medical (NARI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Inari Medical Stock (NASDAQ:NARI) Get Inari Medical alerts:Sign Up Key Stats Today's Range$79.97▼$79.9750-Day Range$79.97▼$79.9752-Week Range$39.76▼$79.99VolumeN/AAverage Volume1.49 million shsMarket Capitalization$4.68 billionP/E RatioN/ADividend YieldN/APrice Target$76.33Consensus RatingHold Company Overview Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Read More Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NARI Stock News HeadlinesVensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture PartnerOctober 7, 2025 | finance.yahoo.com4 medtech topics to watch for the rest of 2025August 25, 2025 | finance.yahoo.comQuiet Tickers. Strong Signals. Here’s What’s Brewing…The final stretch of the year is packed with uncertainty — but while others guess, smart traders focus on verified market activity. Our free Small-Cap Signals Guide shows how to spot early momentum shifts, identify small caps with breakout potential, and understand the setups analysts are watching now.October 16 at 2:00 AM | Market Crux (Ad)SYK Q2 Deep Dive: Tariffs, Supply Chain, and Robotics Weigh on Market SentimentAugust 13, 2025 | msn.comInari Medical’s Protrieve PROTECTOR Study: A Game-Changer in DVT Treatment?August 6, 2025 | tipranks.comStryker (SYK) Raises Guidance As Sales Reach US$6 Billion In Strong Q2August 2, 2025 | finance.yahoo.comStryker raises 2025 outlook amid 17.3% medical surgery and neurotechnology unit riseAugust 2, 2025 | msn.comStryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain ChallengesAugust 1, 2025 | finance.yahoo.comSee More Headlines NARI Stock Analysis - Frequently Asked Questions How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) released its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.09. The company's quarterly revenue was up 22.5% compared to the same quarter last year. Read the conference call transcript. When did Inari Medical IPO? Inari Medical (NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inari Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings2/28/2024Today10/16/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NARI CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees800Year Founded2011Price Target and Rating Average Price Target for Inari Medical$76.33 High Price Target$80.00 Low Price Target$63.00 Potential Upside/Downside-4.5%Consensus RatingHold Rating Score (0-4)2.10 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)($1.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.64 million Net Margins-13.68% Pretax Margin-9.29% Return on Equity-10.09% Return on Assets-6.60% Debt Debt-to-Equity RatioN/A Current Ratio1.77 Quick Ratio1.40 Sales & Book Value Annual Sales$493.63 million Price / Sales9.48 Cash Flow$0.09 per share Price / Cash Flow906.95 Book Value$8.07 per share Price / Book9.91Miscellaneous Outstanding Shares58,540,000Free Float52,338,000Market Cap$4.68 billion OptionableOptionable Beta1.02 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:NARI) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.